pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4732 |
Genomic Coordinates | chr17: 28861655 - 28861730 |
Description | Homo sapiens miR-4732 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4732-5p | |||||||||||||||||||||||||||||||||
Sequence | 9| UGUAGAGCAGGGAGCAGGAAGCU |31 | |||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CD4 | ||||||||||||||||||||
Synonyms | CD4mut | ||||||||||||||||||||
Description | CD4 molecule | ||||||||||||||||||||
Transcript | NM_000616 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CD4 | |||||||||||||||||||||
3'UTR of CD4 (miRNA target sites are highlighted) |
>CD4|NM_000616|3'UTR 1 GGCACGAGGCCAGGCAGATCCCACTTGCAGCCTCCCCAGGTGTCTGCCCCGCGTTTCCTGCCTGCGGACCAGATGAATGT 81 AGCAGATCCCAGGCCTCTGGCCTCCTGTTCGCCTCCTCTACAATTTGCCATTGTTTCTCCTGGGTTAGGCCCCGGCTTCA 161 CTGGTTGAGTGTTGCTCTCTAGTTTCCAGAGGCTTAATCACACCGTCCTCCACGCCATTTCCTTTTCCTTCAAGCCTAGC 241 CCTTCTCTCATTATTTCTCTCTGACCCTCTCCCCACTGCTCATTTGGATCCCAGGGGAGTGTTCAGGGCCAGCCCTGGCT 321 GGCATGGAGGGTGAGGCTGGGTGTCTGGAAGCATGGAGCATGGGACTGTTCTTTTACAAGACAGGACCCTGGGACCACAG 401 AGGGCAGGAACTTGCACAAAATCACACAGCCAAGCCAGTCAAGGATGGATGCAGATCCAGAGGTTTCTGGCAGCCAGTAC 481 CTCCTGCCCCATGCTGCCCGCTTCTCACCCTATGTGGGTGGGACCACAGACTCACATCCTGACCTTGCACAAACAGCCCC 561 TCTGGACACAGCCCCATGTACACGGCCTCAAGGGATGTCTCACATCCTCTGTCTATTTGAGACTTAGAAAAATCCTACAA 641 GGCTGGCAGTGACAGAACTAAGATGATCATCTCCAGTTTATAGACCAGAACCAGAGCTCAGAGAGGCTAGATGATTGATT 721 ACCAAGTGCCGGACTAGCAAGTGCTGGAGTCGGGACTAACCCAGGTCCCTTGTCCCAAGTTCCACTGCTGCCTCTTGAAT 801 GCAGGGACAAATGCCACACGGCTCTCACCAGTGGCTAGTGGTGGGTACTCAATGTGTACTTTTGGGTTCACAGAAGCACA 881 GCACCCATGGGAAGGGTCCATCTCAGAGAATTTACGAGCAGGGATGAAGGCCTCCCTGTCTAAAATCCCTCCTTCATCCC 961 CCGCTGGTGGCAGAATCTGTTACCAGAGGACAAAGCCTTTGGCTCTTCTAATCAGAGCGCAAGCTGGGAGCACAGGCACT 1041 GCAGGAGAGAATGCCCAGTGACCAGTCACTGACCCTGTGCAGAACCTCCTGGAAGCGAGCTTTGCTGGGAGAGGGGGTAG 1121 CTAGCCTGAGAGGGAACCCTCTAAGGGACCTCAAAGGTGATTGTGCCAGGCTCTGCGCCTGCCCCACACCCTCCCTTACC 1201 CTCCTCCAGACCATTCAGGACACAGGGAAATCAGGGTTACAAATCTTCTTGATCCACTTCTCTCAGGATCCCCTCTCTTC 1281 CTACCCTTCCTCACCACTTCCCTCAGTCCCAACTCCTTTTCCCTATTTCCTTCTCCTCCTGTCTTTAAAGCCTGCCTCTT 1361 CCAGGAAGACCCCCCTATTGCTGCTGGGGCTCCCCATTTGCTTACTTTGCATTTGTGCCCACTCTCCACCCCTGCTCCCC 1441 TGAGCTGAAATAAAAATACAATAAACTTACTATAAAGATGCAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000011653.4 | 3UTR | CCUCUGGCCUCCUGUUCGCCUCCUCUACAAUUUGCCAUUGUUUCUCCUGGGUUAGGCCCCGGCUUCACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
65 hsa-miR-4732-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT076214 | ALKBH5 | alkB homolog 5, RNA demethylase | 2 | 2 | ||||||||
MIRT443015 | C21orf91 | chromosome 21 open reading frame 91 | 2 | 2 | ||||||||
MIRT450317 | ZNF562 | zinc finger protein 562 | 2 | 2 | ||||||||
MIRT450522 | ZNF236 | zinc finger protein 236 | 2 | 2 | ||||||||
MIRT453952 | ENTHD1 | ENTH domain containing 1 | 2 | 2 | ||||||||
MIRT463438 | ZC3HAV1L | zinc finger CCCH-type containing, antiviral 1 like | 2 | 2 | ||||||||
MIRT463971 | WHSC1 | nuclear receptor binding SET domain protein 2 | 2 | 4 | ||||||||
MIRT465545 | TOB2 | transducer of ERBB2, 2 | 2 | 2 | ||||||||
MIRT473817 | MAP2K7 | mitogen-activated protein kinase kinase 7 | 2 | 2 | ||||||||
MIRT476716 | FRK | fyn related Src family tyrosine kinase | 2 | 4 | ||||||||
MIRT477373 | ENTPD7 | ectonucleoside triphosphate diphosphohydrolase 7 | 2 | 2 | ||||||||
MIRT477756 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | 2 | 2 | ||||||||
MIRT479642 | CD4 | CD4 molecule | 2 | 2 | ||||||||
MIRT483891 | IL20RB | interleukin 20 receptor subunit beta | 2 | 6 | ||||||||
MIRT485654 | DAZAP2 | DAZ associated protein 2 | 2 | 10 | ||||||||
MIRT493568 | HSP90AA1 | heat shock protein 90 alpha family class A member 1 | 2 | 8 | ||||||||
MIRT499708 | NFATC2IP | nuclear factor of activated T-cells 2 interacting protein | 2 | 10 | ||||||||
MIRT499933 | MFSD8 | major facilitator superfamily domain containing 8 | 2 | 2 | ||||||||
MIRT509169 | EFHC1 | EF-hand domain containing 1 | 2 | 4 | ||||||||
MIRT510594 | TUBB2A | tubulin beta 2A class IIa | 2 | 2 | ||||||||
MIRT510832 | RTN4RL1 | reticulon 4 receptor like 1 | 2 | 6 | ||||||||
MIRT512419 | LAYN | layilin | 2 | 4 | ||||||||
MIRT516109 | OARD1 | O-acyl-ADP-ribose deacylase 1 | 2 | 8 | ||||||||
MIRT517204 | OTUD6A | OTU deubiquitinase 6A | 2 | 2 | ||||||||
MIRT519106 | ALG1 | ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase | 2 | 2 | ||||||||
MIRT519283 | SPCS1 | signal peptidase complex subunit 1 | 2 | 2 | ||||||||
MIRT519823 | ZKSCAN4 | zinc finger with KRAB and SCAN domains 4 | 2 | 2 | ||||||||
MIRT521976 | PFN2 | profilin 2 | 2 | 4 | ||||||||
MIRT526729 | ZNF138 | zinc finger protein 138 | 2 | 2 | ||||||||
MIRT528765 | CD1D | CD1d molecule | 2 | 2 | ||||||||
MIRT531567 | ILDR1 | immunoglobulin like domain containing receptor 1 | 2 | 2 | ||||||||
MIRT532173 | SEC14L5 | SEC14 like lipid binding 5 | 2 | 4 | ||||||||
MIRT534865 | QSER1 | glutamine and serine rich 1 | 2 | 2 | ||||||||
MIRT539948 | SLC30A5 | solute carrier family 30 member 5 | 2 | 2 | ||||||||
MIRT543594 | KIAA1549 | KIAA1549 | 2 | 2 | ||||||||
MIRT543964 | RNF20 | ring finger protein 20 | 2 | 2 | ||||||||
MIRT544747 | C8orf33 | chromosome 8 open reading frame 33 | 2 | 2 | ||||||||
MIRT544871 | EHD3 | EH domain containing 3 | 2 | 2 | ||||||||
MIRT550459 | OSCAR | osteoclast associated, immunoglobulin-like receptor | 2 | 2 | ||||||||
MIRT551950 | RNF157 | ring finger protein 157 | 2 | 2 | ||||||||
MIRT552504 | ZIK1 | zinc finger protein interacting with K protein 1 | 2 | 4 | ||||||||
MIRT554074 | SNX4 | sorting nexin 4 | 2 | 4 | ||||||||
MIRT555952 | NUBP1 | nucleotide binding protein 1 | 2 | 2 | ||||||||
MIRT561097 | VAMP8 | vesicle associated membrane protein 8 | 2 | 2 | ||||||||
MIRT561827 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | 2 | 2 | ||||||||
MIRT563962 | ZNF431 | zinc finger protein 431 | 2 | 2 | ||||||||
MIRT566851 | LRRC58 | leucine rich repeat containing 58 | 2 | 2 | ||||||||
MIRT608133 | TGFBR2 | transforming growth factor beta receptor 2 | 2 | 2 | ||||||||
MIRT615716 | ZNF383 | zinc finger protein 383 | 2 | 2 | ||||||||
MIRT615959 | ERBB3 | erb-b2 receptor tyrosine kinase 3 | 2 | 4 | ||||||||
MIRT620031 | ST6GALNAC3 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 | 2 | 2 | ||||||||
MIRT621102 | IL36B | interleukin 36, beta | 2 | 2 | ||||||||
MIRT627383 | TNNC1 | troponin C1, slow skeletal and cardiac type | 2 | 2 | ||||||||
MIRT628263 | DOK6 | docking protein 6 | 2 | 2 | ||||||||
MIRT635011 | PDHB | pyruvate dehydrogenase E1 beta subunit | 2 | 2 | ||||||||
MIRT636129 | YIPF4 | Yip1 domain family member 4 | 2 | 2 | ||||||||
MIRT646812 | COX19 | COX19, cytochrome c oxidase assembly factor | 2 | 2 | ||||||||
MIRT652099 | TRUB2 | TruB pseudouridine synthase family member 2 | 2 | 2 | ||||||||
MIRT662038 | KSR2 | kinase suppressor of ras 2 | 2 | 2 | ||||||||
MIRT691530 | ZNF208 | zinc finger protein 208 | 2 | 2 | ||||||||
MIRT698030 | TRPV2 | transient receptor potential cation channel subfamily V member 2 | 2 | 2 | ||||||||
MIRT706642 | NCBP2 | nuclear cap binding protein subunit 2 | 2 | 2 | ||||||||
MIRT707919 | PRIMA1 | proline rich membrane anchor 1 | 2 | 2 | ||||||||
MIRT714664 | CHRNE | cholinergic receptor nicotinic epsilon subunit | 2 | 2 | ||||||||
MIRT721201 | ZNF724P | zinc finger protein 724 | 2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|